Primer on Multiple Sclerosis - Tapa blanda

This new volume provides a highly accessible summary of a most dynamic area of medicine, featuring updates by many leading authorities in the field. The new edition of Dr. Geisser's primer has great practical value for all clinicians who care for people with multiple sclerosis. (- Stephen L. Hauser, MD Professor & Chair, Department of Neurology, University of California, San Francisco, CA)

Dr. Barbara S. Giesser's second edition of Primer On Multiple Sclerosis is an impressive and highly successful comprehensive review and synthesis of the huge scientific literature concerning multiple sclerosis. In reading it, one will come to appreciate the remarkable progress we have made and, yet, how much further we still have to go to eliminate this disease from the myriad of sufferings mankind is faced with. I know of no better resource to educate sophisticated patients, clinicians, researchers and health policy advocates about MS. (Timothy Vollmer, MD, Co-Director, RMMSC at Anschutz Medical Director, RMMSC, Director, Neurology Clinical Research, Professor, Department of Neurology, Aurora, CO)

Primer on Multiple Sclerosis, 2nd Edition is an updated reference manual for the practicing clinician. It covers the range of information needed to treat persons with MS, beginning with basic science and immunopathology, thorough differential diagnosis, symptom management and disease modifying therapies. This essential book also includes material covering new and experimental strategies as well as a review of commonly used complementary and alternative modalities that are used by persons with MS.Multiple Sclerosis (MS) is the most common demyelinating disease of the CNS and the third most common cause of disability among young adults. The complex management issues that are often present in the care of individuals with MS may demand the participation of health care professionals from a variety of disciplines, although the team is usually led by a neurologist. It is therefore essential for the neurologist to have a thorough grounding in the basic science and clinical phenomenology of MS.

In this second edition of Primer on Multiple Sclerosis, the latest updates on therapeutics are provided, including new medications that have been FDA- approved since the first edition. Includes new diagnostic criteria, as well as any advances made in current diagnostic techniques, e.g. new imaging metrics. Important new information in the basic sciences and pathophysiology of MS is provided as well as newer epidemiologic studies. Treatment algorithms for common symptoms will be expanded, as well as any new guidelines for switching medications for Disease Modifying treatment "failures". The chapter on alternative and complimentary therapies discusses new research on CCSVI. The chapter on legal issues includes information on the putative effect of the Affordable Health Care Act on access to neurologic care and treatments. Finally, there is expanded discussion of progressive forms of MS both from a basic science and treatment perspective.